Delivery Order SPE2DB20D1100-SPE2DB25FC7B1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor under its broader pharmaceutical supply framework, for Varenicline 1 mg tablets (56-count packaging) on April 21, 2025. This non-set-aside, competitively awarded contract is valued at $1,449.00 with a firm fixed price structure and an ultimate completion date of April 22, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,316.60 to AmerisourceBergen Drug Corp for Varenicline 1 mg tablets (56-count packages) on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-competitive, firm fixed-price delivery order represents a small-value pharmaceutical supply transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Varenicline 1 mg tablets (56-count packaging). This firm fixed-price contract, valued at $1,797.36, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The delivery order was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Varenicline 1 mg tablets (56-count packaging) with a contract value of $1,222.62. This firm fixed-price delivery order is set to be completed by October 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement, reflecting the agency's confidence in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Varenicline 1 mg tablets (56-count packaging) with a ceiling value of $2,360.02 and a firm fixed price structure. This is a non-set-aside competitively awarded contract with an ultimate completion date of July 16, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a small-value transaction...
- The Defense Logistics Agency awarded a $1,007.15 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Varenicline 1 mg tablets (56-count packages). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the company's corporate headquarters location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varenicline 1 mg tablets (56-count packaging) under a firm fixed-price contract valued at $1,650.82. The contract, effective May 8, 2025, with an ultimate completion date of May 9, 2025, represents a non-set-aside competitive award for pharmaceutical distribution to support federal medical procurement needs. Performance will be executed from the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Varenicline 1 mg tablets (56-count packages) valued at $1,637.64. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child contract under the vendor's...
- The Defense Logistics Agency awarded a $7,432.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Varenicline 1 mg tablets (56-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,827.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 56 tablets of Varenicline 1 mg on September 24, 2025, with completion expected by September 25, 2025. This is a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The company, headquartered in...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC7B1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,666.72 to AmerisourceBergen Drug Corp for the supply of Varenicline 1 mg tablets (56-count packages). This firm fixed-price, non-set-aside contract was awarded on June 4, 2025, with an ultimate completion date of June 5, 2025. The pharmaceutical products will be performed and delivered from AmerisourceBergen's location in Conshohocken, Pennsylvania. Varenicline is a prescription medication commonly used to support smoking cessation efforts, making this procurement relevant to military and federal healthcare system wellness initiatives. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor agreement enables AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including customers such as the Defense Health Agency and U.S. Coast Guard. The company's federal contracting portfolio demonstrates its established capability to fulfill competitive pharmaceutical procurement requirements across multiple therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/4/25 |